Danish pharmaceutical company Novo Nordisk joined forces with Thai authorities in a public-private initiative to promote healthier urban living. As part of World Obesity Day 2025, the company participated in the Chula Obesity Day event, organized by Chulalongkorn University, aligning with the global theme “Changing Systems, Healthier Lives.”
The event brought together policymakers, including the Thai Health Promotion Foundation and the Bangkok Metropolitan Administration (BMA), to address Thailand’s rising obesity rates. Novo Nordisk highlighted its ‘Cities for Better Health’ initiative, which aims to reduce health inequalities and improve prevention efforts in urban settings.
“Obesity is a major challenge in large cities like Bangkok—too complex for any single entity to tackle alone,” said Enrico Cañal Bruland, General Manager of Novo Nordisk Pharma Thailand, emphasizing the importance of multisectoral collaboration.
By engaging in this initiative, Novo Nordisk reinforces its commitment to tackling obesity on a global scale, with Bangkok potentially joining its growing network of partner cities.
